SightfileU.S. market data from official filings

Companies › HOWL

Werewolf Therapeutics Inc (HOWL)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001785530 · EDGAR filings · Updated 2026-07-08

Werewolf Therapeutics Inc (HOWL) has reported institutional ownership of 28.8%, with 48 institutional managers holding positions valued at $11.7M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
28.8%
Institutional managers
48
Reported 13F value
$11.7M
Insider activity
120 trans.
−$6.05M net selling
Data flags
2 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Werewolf Therapeutics Inc has 48 institutional holders and institutional ownership of 28.8%.

Insider activity

Insiders reported 120 transactions (3 buys, 114 sells) across 13 reporting insiders, with a net reported value of −$6.05M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-07 (recurring since 2025-11-04) — source filing. The authoritative details are those stated in the filing itself.
Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2026-02-06 (recurring since 2025-05-15) — source filing. The authoritative details are those stated in the filing itself.

Related companies

KAZIA THERAPEUTICS LTD (KZIA) · ATARA BIOTHERAPEUTICS COM NEW (ATRA) · FITLIFE BRANDS INC (FTLF) · ENVOY MEDICAL INC (COCH) · Clene Inc (CLNN) · Aytu BioPharma Inc (AYTU)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-08.